Primary Sclerosing Cholangitis

PSC is a rare liver disease causing chronic inflammation and scarring of the bile ducts.

✦ AI summary

Primary sclerosing cholangitis (PSC) is a rare condition where the bile ducts become inflamed and scarred over time, and research describes it as "intractable" with no fully effective treatments yet, mostly affecting younger people and carrying a meaningful impact on families and healthcare costs [10]. A major challenge highlighted in the sources is diagnosis itself: PSC has no single definitive test, can be confused with "secondary" causes of bile duct scarring (like chemotherapy-related injury) [12], and this uncertainty can cause real psychological distress and delays in care — prompting researchers to develop and validate a clinical prediction tool (PSC-DM) using features like younger age, inflammatory bowel disease, and autoimmune family history to help tell PSC apart from look-alike conditions [5]. Scientists are also studying the underlying biology, including gut-liver-microbiome interactions [3], immune cell communication in the bile ducts [10], regulatory immune cells [11], and specific molecular signals that may explain why some people with PSC-related colitis face higher colorectal cancer risk [7]. Some patients also have overlapping features with autoimmune hepatitis, a subset ("variant syndrome")

This is an AI-generated summary of the sources below — not medical advice. Always talk to a doctor or pharmacist about your own situation.

No content indexed yet for Primary Sclerosing Cholangitis.

The database is updated nightly. Check back soon.

People also search for